Dexin Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 552.01 million compared to TWD 1,231.22 million a year ago. Net loss was TWD 50.76 million compared to net income of TWD 60.16 million a year ago.

Basic loss per share from continuing operations was TWD 1.3 compared to basic earnings per share from continuing operations of TWD 1.7 a year ago. Diluted loss per share from continuing operations was TWD 1.3 compared to diluted earnings per share from continuing operations of TWD 1.69 a year ago.